Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanlong Li

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severityPhillip C C Liu, Eian Caulder, Jun Li, et al.
Blood|February 5, 2010
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsAlfonso Quintás-Cardama, Kris Vaddi, Phillip Liu, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma modelEddy W Yue, Brent Douty, Brian Wayland, et al.
The New Phytologist|March 5, 2021
A combination of genome-wide and transcriptome-wide association studies reveals genetic elements leading to male sterility during high temperature stress in cottonYizan Ma, Ling Min, Junduo Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2011
Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infectionNiu Shin, Kim Solomon, Naiming Zhou, et al.
European Journal of Pharmacology|December 14, 2011
INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functionsNiu Shin, Maryanne Covington, Di Bian, et al.
Cancer Cell|July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancerBin-Bing S Zhou, Michael Peyton, Biao He, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Blood|March 4, 2010
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunityXiangdong Liu, Niu Shin, Holly K Koblish, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severityPhillip C C Liu, Eian Caulder, Jun Li, et al.
Blood|February 5, 2010
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsAlfonso Quintás-Cardama, Kris Vaddi, Phillip Liu, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma modelEddy W Yue, Brent Douty, Brian Wayland, et al.
The New Phytologist|March 5, 2021
A combination of genome-wide and transcriptome-wide association studies reveals genetic elements leading to male sterility during high temperature stress in cottonYizan Ma, Ling Min, Junduo Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2011
Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infectionNiu Shin, Kim Solomon, Naiming Zhou, et al.
European Journal of Pharmacology|December 14, 2011
INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functionsNiu Shin, Maryanne Covington, Di Bian, et al.
Cancer Cell|July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancerBin-Bing S Zhou, Michael Peyton, Biao He, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Blood|March 4, 2010
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunityXiangdong Liu, Niu Shin, Holly K Koblish, et al.
Pageof 18